So this is the bandwagon many melanoma specialists are on at the moment as is evident by this article and the two recent posts noted below - all from differing sets of researchers! And, that's not a bad thing. My cynical self sees it as a race to the patented, FDA approved, money making test...for this bio-firm or for that set of researchers. My more hopeful self sees a potential method for minimally invasive, accurate diagnosis of the presence and type of melanoma an individual is dealing with, as well as a way to measure tumor burden and response to therapy.
Here's hoping! - c